These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36910430)

  • 1. Plasminogen activator inhibitor-1 levels as an indicator of severity and mortality for COVID-19.
    Baycan OF; Barman HA; Bolen F; Atici A; Erman H; Korkmaz R; Calim M; Atalay B; Aciksari G; Cekmen MB; Vahaboglu H; Caliskan M
    North Clin Istanb; 2023; 10(1):1-9. PubMed ID: 36910430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy is Initiated with Endothelial Dysfunction and Disrupted Fibrinolysis in Patients with COVID-19 Disease.
    Belen Apak FB; Yuce G; Topcu DI; Gultekingil A; Felek YE; Sencelikel T
    Indian J Clin Biochem; 2023 Apr; 38(2):220-230. PubMed ID: 36816717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
    Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
    Sci Rep; 2021 Jan; 11(1):1580. PubMed ID: 33452298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
    Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
    medRxiv; 2020 Dec; ():. PubMed ID: 32909005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
    Moore HB; Moore EE; Huebner BR; Dzieciatkowska M; Stettler GR; Nunns GR; Lawson PJ; Ghasabyan A; Chandler J; Banerjee A; Silliman C; Sauaia A; Hansen KC
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1014-1022. PubMed ID: 29190254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chest CT Total Severity Score on Admission to Predict In-Hospital Mortality in COVID-19 Patients with Acute and Chronic Renal Impairment.
    Tharwat S; Saleh GA; Saleh M; Mounir AM; Abdelzaher DG; Salah AM; Nassar MK
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study.
    Juneja GK; Castelo M; Yeh CH; Cerroni SE; Hansen BE; Chessum JE; Abraham J; Cani E; Dwivedi DJ; Fraser DD; Slessarev M; Martin C; McGilvray S; Gross PL; Liaw PC; Weitz JI; Kim PY;
    J Thromb Haemost; 2021 Jun; 19(6):1546-1557. PubMed ID: 33826233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis.
    Tipoe TL; Wu WKK; Chung L; Gong M; Dong M; Liu T; Roever L; Ho J; Wong MCS; Chan MTV; Tse G; Wu JCY; Wong SH
    Front Immunol; 2018; 9():1218. PubMed ID: 29967603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFPI and FXIII negatively and S100A8/A9 and Cystatin C positively correlate with D-dimer in COVID-19.
    Gupta A; Qaisar R; Halwani R; Kannan M; Ahmad F
    Exp Biol Med (Maywood); 2022 Sep; 247(17):1570-1576. PubMed ID: 35723053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A.
    Soliman M; Osman N; Hefnawy S; El Hawy MA
    Pediatr Hematol Oncol; 2022 May; 39(4):318-328. PubMed ID: 34668834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study.
    Corey KM; Olson LB; Naqvi IA; Morrison SA; Davis C; Nimjee SM; Que LG; Bachelder RE; Kraft BD; Chen L; Nair SK; Levy JH; Sullenger BA
    Anesthesiology; 2022 Jul; 137(1):67-78. PubMed ID: 35412597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma levels of PAI-1 predict cardiovascular events and cardiovascular mortality in prevalent peritoneal dialysis patients.
    Arikan H; Koc M; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2009; 31(6):438-45. PubMed ID: 19839820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients.
    Lorente L; Martín MM; Borreguero-León JM; Solé-Violán J; Ferreres J; Labarta L; Díaz C; Jiménez A; Páramo JA
    Thromb Res; 2014 Jul; 134(1):182-6. PubMed ID: 24814968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality Predictors in Patients Diagnosed with COVID-19 in the Emergency Department: ECG, Laboratory and CT.
    Türkay Kunt A; Kozaci N; Torun E
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204209
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis.
    Salvatore C; Roberta F; Angela L; Cesare P; Alfredo C; Giuliano G; Giulio L; Giuliana G; Maria RG; Paola BM; Fabrizio U; Roberta G; Beatrice F; Vittorio M
    Radiol Med; 2021 Jan; 126(1):29-39. PubMed ID: 33047295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study.
    Tofler GH; Massaro J; O'Donnell CJ; Wilson PWF; Vasan RS; Sutherland PA; Meigs JB; Levy D; D'Agostino RB
    Thromb Res; 2016 Apr; 140():30-35. PubMed ID: 26896607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO; Muddathir AR; Rida M; Rayis DA; Elhassan EM; Adam I
    Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.